Bad pharma
AllTrials campaign releases manifesto
August 9, 2013Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency
The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
Bad pharma, good pharma: an insider’s view
May 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy
Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …
Pharma pays doctors £40m
April 9, 2013Sales and Marketing ABPI, Bad pharma, ethics
Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency
You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
GSK announces AllTrials support
February 6, 2013Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre
GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …
Payments register moves closer
January 29, 2013Sales and Marketing Bad pharma, Goldacre, NHS, doctors, pharma
Greater transparency around the payments made by pharma companies to doctors looks to have moved a step closer with a …
MPs pharma investigation in offing
November 26, 2012Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data
A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …
Goldacre is right – greater honesty is needed
November 7, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose
One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …
